PP
Therapeutic Areas
PolTREG Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PTG007 | Type 1 Diabetes (newly diagnosed) | Phase I/II |
| Next-Gen CAR-Tregs | Multiple Sclerosis (MS) | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| PTG007 | Type 1 Diabetes (newly diagnosed) | Phase I/II |
| Next-Gen CAR-Tregs | Multiple Sclerosis (MS) | Preclinical |